Blog

Global WACh Researchers Share Latest Science at CROI 2019

Last week, Global WACh researchers participated in the Conference on Retroviruses and Opportunistic Infections (CROI) held in Seattle from March 5-7, 2019.  The annual conference brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.  Our researchers shared their latest findings on testing for HIV, human papillomavirus (HPV), tuberculosis (TB), and on PrEP delivery practices.  Continue reading for highlights and a list of accepted posters by Global WACh researchers.

Key Considerations for the “Last Mile of EMTCT
Monday, March 4th

On March 4th, Global WACh and UNICEF, in partnership with WHO, co-convened an off-site technical consultation on key considerations for the “last mile” of programming to end mother to child HIV transmission (EMTCT).  Over the past decade, bold policies have catalyzed important programmatic leaps to prevent and reduce transmissions from mother to child.  As the world nears international targets for EMTCT, progress is slowing, and the broad, one-size-fits-all approaches may no longer be sufficient to optimize programs and reach those in greatest need.  Informed by the expertise of an outstanding panel of HIV/AIDS and infectious disease researchers, the consultation focused on a preliminary conceptual framework that considers the in-country realities for programs targeting EMTCT and could direct new interventions and guide program development.

Meeting Chairs:

Panel Speakers:

Global WACh Posters and Presentations Featured at CROI
Tuesday, March 5th

Wednesday, March 6th

 

 

 

 

 

 

 

 

 

 

 

 

 

Thursday, March 7th

  • Concordance of HIV Risk Perception and Empiric Risk Score Among Pregnant Kenyan Women
    Laurén Gómez, John Kinuthia, Julia C. Dettinger, Jillian Pintye, Anjuli D. Wagner, Nancy M. Ngumbau, Ben O. Odhiambo, Mary M. Marwa, Salphine A. Wattoyi, Felix Abuna, Joshua Stern, Grace John-Stewart, Jared Baeten
  • Persistence with PrEP Use in African Adolescents and Young Women Initiating PrEP
    Kenneth K. Mugwanya, Jillian Pintye, John Kinuthia, Harrison Lagat, Felix Abuna, Emily R. Begnel, Julia C. Dettinger, Grace John-Stewart, Jared Baeten
  • Low uptake of Pre-exposure Prophylaxis Among Kenyan Adolescent Girls at Risk of HIV (Oral Presentation)
    Lynda M. Oluoch, Nelly R. Mugo, Alison C. Roxby, Anna Wald, Stacy Selke,
    Amalia Magaret, Kenneth Ngure, Murugi Micheni, Steven Gakuo, Bhavna
    Chohan, Catherine Kiptinness
  • Point-of-Care Creatinine Testing Within a Programmatic PrEP Delivery Setting (Oral Presentation)
    Jillian Pintye, Felix Abuna, John Kinuthia, Harrison Lagat, Kenneth K. Mugwanya, Julia Dettinger, Emily R. Begnel, Marline Serede, Joseph Sila, Jared Baeten, Grace John-Stewart

    Dr. Pintye is an Acting Assistant Professor in Family and Child Nursing in the UW School of Nursing, and is an investigator on the DREAMS/PEPFAR-funded PrEP Implementation for Young Women and Adolescents (PrIYA) Program. Kenyan national PrEP guidelines currently mandate creatinine testing to identify pre-existing renal disease prior to PrEP implementation. Dr. Pintye’s research suggests testing is feasible during PrEP delivery within maternal-child and family planning settings to reduce testing-related time, costs, and inconvenience.